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Summary.-The previously described glycoprotein that promotes tumour cell
aggregation, derived from rat ascites hepatoma cells and capable of partial purifica-
tion by chromatography, was found to be a mixture of 2 factors with different anti-
genic property. One was not absorbed by immunoadsorbent chromatography with
anti-rat serum antibody and the other was. The action of the unabsorbed factor was
clearly more potent than that of the absorbed factor. Both the factors were found in
the serum of tumour bearing rats and the action of the unabsorbed factor was also
more potent than that of the absorbed factor; its amount increased with time after
i.p. inoculation of the cells. The serum of healthy rats contained the absorbed
factor but not the unabsorbed factor. It was thus assumed that the unabsorbed
factor was associated with the hepatoma cell surface itself and released into the
serum, while the absorbed factor was associated with serum protein coating the cell.
As PREVIOUSLY described (Kudo et
al., 1974), a substance capable ofinducing
tumour cell aggregation, which is probably
a glycoportein with no cytotoxicity, has
been separated from rat ascites hepatoma
cells and partially purified by chromato-
graphy. The thermostable substance was
clearly effective for rat ascites hepatoma
cells as well as SV40 transformed cells,
but not for normal rat liver cells and red
blood cells. The action of this material
was more potent than that of Jack bean
concanavalin A (con A) and it was
suggested that this material may have a
binding site on the cell surface, different
from the site for con A, because its effect
was not influenced by con A inhibitors.
Adhesiveness of rat ascites hepatoma
cells induced by this substance was
characterized by gradual development of
known binding structures; simple apposi-
tion and intermediate junction developed
in the early stage, and desmosome and
focal tight junction in the later stage
(Ishimaru, Ishihara and Hayashi, 1975).
It was thus assumed that the substance
might be involved in the development of
such binding structures as a triggering
mechanism of tumour cell adhesiveness.
The purpose of the present communica-
tion is to record the evidence that the
substance described above is a mixture
of 2 tumour cell aggregation inducing
factors with different antigenic property;
the one may be associated with hepatoma
cell surface and the other with serum
protein coating the cell surface.
MATERIALS AND METHODS
Rat ascites hepatoma.-Rat ascites hepa-
toma AH136B (Odashima, 1962) andAH109A
(Odashima, 1964) have been maintained in
our laboratory by routine 10-day interval
passage of 1 x 106 AH136B cells or by
routine weekly passage of 2 x 106 AH109A
cells injected i.p. into 80-100 g male rats
of the Donryu strain. The majority (about
98%) of AH136B cells were found to form
cell islands of varying size in vivo. On the
other hand, most (about 98%) of AH109A
cells were found to be free in vivo.
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In vitro assay for cell aggregation. This
was performed essentially by the method
previously described (Kudo et al., 1974).
One ml of the test sample at the same
concentration (absorbancy 0 5 at 280 nm/ml)
was mixed with 1 ml of cell suspension in
a Falcon tube (1-5 x 9-5 cm) and incubated
at 37°C in a roller tube culture apparatus,
model Te-Her (Hirasawa Co., Tokyo, Japan)
run at one rotation/8 min. At 30 min after
incubation, cell aggregation in both gross
and microscopic features was recorded. The
grading of the induced cell aggregation was
achieved by counting the aggregating cells
and floating cells respectively in the fluid
at 30 min of incubation, at which macro-
scopic cell aggregation became satisfactory.
The intensity of cell aggregation was roughly
graded as follows: ++, over 70 + 5%
of originally suspended cells were aggre-
gated; +, over 50 ± 50o aggregated; ±,
over 30 + 500 aggregated; and -, below
20% aggregated. All the samples described
below were tested after dialysis against
Hanks' balanced salt solution for 12 h.
Preparation of cell suspension. AH109A
cell suspension was prepared as follows
(lshimaru et al., 1975): the ascites fluid
(20 ml) withdrawn by i.p. puncture 7 days
after inoculation ofAH109A cells and diluted
1: 5 with 0450% NaCl solution. After
washing with 3 changes of 0-4500 NaCl and
2 changes of Hanks' balanced salt solution,
tumour cells were sedimented by centrifuga-
tion at 25 g for 10 min. The cells were
finally suspended at a concentration of
1 5 x 106 cells/ml in Hanks' balanced salt
solution. As previously described (Ishimaru
et al., 1975), the aggregation promoting
factor, separated from AH136B cells, showed
a similar effect for aggregation of AH109A
cells when tested at concentration of 5 x 105
cells/ml (Kudo et al., 1974). The cell
suspension was convenient for the present
experiment because the majority of AH109A
cells were present in a free form in vivo.
On the other hand, AH136B cells needed
previous dissociation, because of in vivo
island formation of the cells (Kudo et al.,
1974).
Isolation of aggregation promiaoting factor
from tumour cells (tumnour cell APF). This
was carried out essentially by the method
previously described (Kudo et al., 1974).
APF was released from 15 x 108 AH136B
cells, suspended in Hanks' balanced salt
solution (free of calcium and magnesium),
received 50 gentle pipettings and was then
allowed to stand for 3 h in the cold (0°C).
The supernatant fluid, obtained after centri-
fugation at 300 g for 10 min and then at
10,000 g for 30 min, was filtered through
Millipore filters (pore size 0-3 /um). The
supernatant fluid (10-20 ml, absorbancy
5-7 at 280 nm/ml) wAas applied to a column
(2 0 x 20-0 cm) of DEAE-Sephadex equi-
librated with 0-02 mol/l phosphate buffer
(pH 6.8). The flowr rate was 20 ml/h and 5 g
effluent fractions w%ere collected. The second
peak (eluted in 0-02 mol/l plhosphate buffer
plus 0-3 mol/l NaCl on DEAE-Sephadex;
5 ml, absorbancy 4-6 at 280 nm/ml) was
placed on a Biogel A-5m column (2-0 x 90.0
cm) equilibrated -with Hanks' balanced salt
solution. Filtration was performed at a
rate of 5 drops/min and 4 g effluent fractions
were collected. The second component was
used as tumour cell APF.
Preparation of antisera and antibody.-
Antisera against rat serum were prepared
in rabbits (2-5-3-0 kg) by repeated intra-
derinal injections of healthy rat serum
(0 5 ml, once per w8eek, 6-8 w-eeks) with
Freund's complete adjuvant (Difco, Detroit,
Michigan, U.S.A.). Only antisera w%ith titres
of 27-28, measured by routine precipitin
test, were used. From the antisera, the
antibody fraction was separated at 3300
saturation with ammonium sulphate. Anti-
sera against tumour cell APF or unabsorbed
tumour cell APF, as described below, were
respectively prepared in rabbits (2-5-3-0 kg)
by repeated intradermal injections of each
APF (3 mg, once per wieek, 6-8 weeks)
with Freund's complete adjuvant; intra-
dermal injections, in divided dose, were
given at 30 sites in the back, abdomen and
proximal limbs of the animals. One w-eek
later, a booster injection (3 mg APF in
20 ml of physiological saline containing
0 5 mg antihistamine) (Polaramine, Schering
Co., Bloomfield, New Jersey, U.S.A.) was
given, followed by a similar injection one
w%Neek later. Only antisera with titres of
26-2 , measured by routine precipitin test,
wN-ere used.
Preparation of im,munooadsorbent colunr,n
With Sepharose 4B coupled with anti-rat
serumn antibody.-The antibody fraction, sepa-
rated from rabbit antisera against normal
rat serum, was coupled w%Nith Sepharose 4B
(Pharmnacia, Uppsala, Sweden) according to
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the method of Porath, Axen and Ernback
(1967). At room temperature, 40 ml of
cyanogen bromide (25 mg/ml in distilled
water) were added to a volume of Sepharose
4B suspension corresponding to 10 g Sepha-
rose. The pH was rapidly adjusted to 11
and kept constant for 6 min by continuous
addition of 2-0 mol/l sodium hydroxide.
The reaction mixture was gently stirred
during the process. The gel was immediately
washed on a glass filter with ice water, and
mixed with the antibody fraction (800 mg)
which was dialysed against 01 mol/l sodium
hydrogen carbonate for 16 h at 4°C. After
sitrring gently for 16 h at 4°C, the mixture
was washed on a glass filter with 0-1 mol/l
sodium hydrogen carbonate to remove free
protein and then with 0-02 mol/l phosphate
buffer (pH 6.8).
Estimation of protein concentration.-This
was performed by the method of Lowry et
al. (1951) using bovine serum albumin as a
standard. However, in the course of chro-
matography, protein concentrations were
shown by the absorbancy at 280 nm/ml.
RESULTS
I. Separation of two different aggregation
promoting factors from tumour cells by
immunoadsorbent chromatography
(a) Immunodiffusionanalysis oftumour
cell APF.-Since it was supposed that
ascites hepatoma cells were coated with
serum protein and retained the protein
in spite of careful washing of the cells,
immunological assay with rabbit antisera
against APF was performed on the APF.
Agar immunodiffusion, pH 8'6, ,um = 0 1,
was carried out according to the method
of Ouchterlony (1958). The tumour cell
FIG. 1. Agar immunodiffusion of tumour cell APF eluted on Biogel. The APF gave 2 distinct
precipitin lines, one weak precipitin line and a diffusely precipitated faint mass with rabbit anti-
serum against the APF. Normal serum APF eluted on Biogel gave 3 weak precipitin lines and
a diffusely precipitated faint mass with the antiserum noted above. A, rabbit antiserum against
tumour cell APF; 1 and 2, tumour cell APF (3 mg/ml); 3 and 4, normal serum APF (10 mg/ml).
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APF gave 2 distinct precipitin lines, one
weak precipitin line, and diffusely pre-
cipitated faint mass when tested with
rabbit antiserum against the APF (1, 2
in Fig. 1). On the other hand, the
normal serum APF, which was similarly
eluted on DEAE-Sephadex and then on
Biogel, as described below, gave 3 weak
precipitin lines and diffusely precipitated
faint mass when tested with the same
antiserum as mentioned above (3, 4 in
Fig. 1). Obvious fusion between the lines
by tumour cell APF and serum APF
was not revealed. It was thus suggested
that tumour cell APF sample contained
some components of serum.
(b) Immunoadsorbent chromatography
of tumour cell APF.-The APF from
tumour cells was concentrated under
vacuum pressure dialysis to give an
adsorbancy 2-3 at 280 nm/ml. Five ml
of the concentrated APF were applied
to a column (2.0 x 8 0 cm) of Sepharose
4B coupled with rabbit anti-rat serum anti-
body previously equilibrated with 0-02
mol/l phosphate buffer (pH 6.8). Elution
was done by change of eluting buffers as
follows: (1) 0-02 mol/l phosphate buffer
(pH 6-8) and (2) 1-0 mol/l acetic acid
(pH 2.4). The flow rate was 18 ml/h
and 5 g effluent fractions were collected.
The total yield was about 990 of the
applied sample measured as the absor-
bancy at 280 nm; the first comprised
67%o and the second 32%. The first
(unabsorbed) component was clearly po-
tent for aggregation of AH109A cells
(Fig. 2a). On the other hand, the potency
of the second (absorbed) component was
apparently less marked (Fig. 2a). In
order to avoid a problem due to column
overloading, the first (unabsorbed) com-
ponent was re-chromatographed under
the same conditions as mentioned above.
The recovery of the applied sample was
about 970/ and concentrated in the first
(unabsorbed) component; the component
was similarly active (Fig. 2b). When the
assay was done by agar immunodiffusion
with rabbit antiserum against the unab-
sorbed component, i.e., unabsorbed tu-
mour cell APF, the unadsorbed APF
gave only 2 distinct precipitin lines
(1, 2 in Fig. 3), but the normal serum
APF (eluted on Biogel) did not give any
precipitin line (3, 4 in Fig. 3). It was
thus suggested that the unabsorbed tu-
mour cell APF may have the different
antigenic property with normal serum
APF.
II. Separation of 2 different aggregation
promoting factors from tumour bearing
rat serum by immunoadsorbent chromato-
graphy
(a) Detection of aggregation promoting
factors in the serum of normal and tumour
bearing rats.-The serum was freshly
harvested from healthy and tumour bear-
ing rats (at 6 and 9 days after i.p. inocula-
tion of 1 x 106 AH136B cells) respect-
ively. According to the method pre-
viously described (Kudo et al., 1974),
each serum sample (3-4 ml, absorbancy
40-60 at 280 nm/ml) was applied to a
column (2 0 x 20.0 cm) of DEAE-Sepha-
dex A-50 equilibrated with 0-02 mol/l
phosphate buffer (pH 6.8), and eluted by
stepwise concentration changes of eluting
buffers. APF, eluted in 0-02 mol/l phos-
phate buffer plus 0 3 mol/l NaCl, was
further eluted on Biogel equilibrated with
Hanks' balanced salt solution; and the
second component eluted was used as
the serum APF. APF activity of tumour
bearing rat serum was more potent than
that of healthy rat serum, and seemed
to increase gradually according to the
duration after i.p. inoculation of the cells
(Table).
(b) Immunoaddsorbent chromatography
of normal and tumour serum APF.-The
APF samples from the sera of healthy
and tumour bearing rats were concen-
trated under vacuum pressure dialysis to
give an absorbancy 3-4 at 280 nm/ml.
Five ml of the concentrated samples
were applied to an immunoadsorbent
column (2-0 x 8.0 cm) prepared by the
same method as mentioned above and
eluted. The flow rate was 18 ml/h and
5 g effluent fractions were collected.
83K. KUDO, Y. HANAOKA AND H. HAYASHI
FiG. 3. Agar immunodiffusion of unabsorbed tumour cell APF after immunoadsorbent chromato-
graphy. The APF gave only 2 distinct precipitin lines with rabbit antiserum against the APF,
showing disappearance of one weak precipitin line and diffusely precipitated mass demonstrated
in Fig. 1. Normal serum APF did not give any precipitin line with the antiserum. A, rabbit
antiserum against unabsorbed tumour cell APF after immunoadsorbent chromatography; 1 and
2, unabsorbed tumour cell APF (3 mg/ml); 3 and 4, normal serum APF eluted on Biogel (10
mg/ml).
TABLE.-Aggregation Promoting Effect of
Serum of Healthy and Tumour Bearing
Rats
Dilution
of
samples
lx
2x
4x
8x
16x
Medium
Factor from
Factor from AH136B
normal bearing
rat serum rat serum*
+
Factor from
AH136B
bearing
rat serumt
+
+
+
Each sample was obtained after gel filtration
on Biogel and tested at the same concentration
(absorbancy 0 5 at 280 nm/ml).
* Serum was obtained 6 days after i.p. inocula-
tion of tumour cells.
t Serum was obtained 9 days after i.p. inocula-
tion of tumour cells.
The total yield was about 99% of the
applied tumour serum APF samples,
measured as the absorbancy at 280nm;
the first comprised 42% and the second
57% (Fig. 4a). The first component was
more potent for AH109A cell aggregation
than the second component. The first
component was re-chromatographed under
the same conditions as described above.
The recovery of the applied sample was
about 99%; the first comprised 57% and
the second 42% (Fig. 4b). The first
component was more active than the
second component. In order to obtain
precise results, the first component was
further re-chromatographed under the
same conditions as noted above. The
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FIG. 4c.-Further re-chromatography of unabsorbed tumour serum APF under the same conditions
as mentioned above. APF activity was assayed at the same concentration (absorbancy 0-5 at
280 nm/ml).
recovery of the applied sample was about
98% and concentrated in the first com-
ponent; the component was clearly active
(Fig. 4c). On the other hand, APF
activity of normal rat serum, although
apparently less marked, was found only
inthe second(absorbed)component(Fig.5).
When the APF samples after re-
chromatography were tested by agar im-
munodiffusion, the unabsorbed tumour
serum APF gave only one distinct pre-
cipitin line with antiserum against the
unabsorbed tumour cell APF noted above
(2 in Fig. 6), but the absorbed tumour
serum APF produced no precipitin line
with the same antiserum (1 in Fig. 6),
indicating that the unabsorbed tumour
serum APF shares antigenic sites common
with the unabsorbed tumour cell APF,
but not with the adsorbed tumour serum
APF. On the other hand, the absorbed
tumour serum APF gave 2 distinct
precipitin lines and one weak precipitin
line with antiserum against normal rat
serum (3 in Fig. 6), but the unabsorbed
tumour serum APF did not give any
precipitin line with the antiserum (2 in
Fig. 6). Further agar immunodiffusion
analysis confirmed the following: the
unabsorbed tumour serum APF gave only
one distinct precipitin line with anti-
serum against the unabsorbed tumour
cell APF noted above (1 in Fig. 7),
which fused obviously one of 2 precipitin
lines produced by the unabsorbed tumour
cell APF and the antiserum (2 in Fig. 7).
The absorbed normal serum APF (3 in
Fig. 7) or the unabsorbed normal serum
component (4 in Fig. 7) produced no
precipitin line with the antiserum de-
scribed above, indicating that the ab-
sorbed normal serum APF has the dif-
ferent antigenic property with the un-
absorbed tumour cell and serum APF.
86
ITUMOUR CELL AGGREGATION PROMOTING FACTOR
o
0
a)
Fraction Number
FIa. 5.-Immunoadsorbent chromatography of normal serum APF elute(d on Biogel. Each effluent fraction was tested at the same concentration (absorbancy 0 5 at 280 nm/ml) for aggregation activity.
DISCUSSION
The observations presented here de-
monstrated that a tumour cell APF,
isolated from rat ascites hepatoma cells
by the method previously described (Kudo
et al., 1974), was a mixture of at least
2 factors with different antigenic deter-
minants. The one, which is clearly more
potent for induction of AH109A cell
aggregation, was not absorbed by im-
munoadsorbent chromatography with
anti-rat serum antibody, i.e., unabsorbed
tumour cell APF. On the other hand,
the other, which is apparently less active,
was absorbed by the antibody, i.e.,
absorbed tumour cell APF. On the
basis of observations that tumour cells
used were floating in the ascitic fluid in
vivo, it was assumed that the unabsorbed
tumour cell APF may be related to the
surface protein of tumour cells them-
selves, but the absorbed tumour cell
APF to the serum protein coating the
tumour cell surface. In this connection,
it was important to note that the serum
of tumour bearing rats contained 2
tumour cell aggregation promotingfactors,
which could be differentiated by immuno-
adsorbent chromatography with anti-rat
serum antibody, i.e., absorbed and un-
absorbed tumour serum APF. The un-
absorbed tumour serum APF was also
more potent for induction of AH109A
cell aggregation than the absorbed APF,
87K. KUDO, Y. HANAOKA AND H. HAYASHI
FIG. 6. Agar immunodiffusion of tumour serum APF after immunoadsorbent chromatography.
The unabsorbed tumour serum APF gave one distinct precipitin line with rabbit antiserum against
the unadsorbed tumour cell APF, but did not produce any precipitin line with rabbit antiserum
against normal rat serum. The absorbed tumour serum APF produced 2 distinct and one weak
precipitin lines with antiserum against normal rat serum, but not with antiserum against the
unabsorbed tumour cell APF. A, rabbit antiserum against unabsorbed tumour cell APF; B,
rabbit antiserum against normal rat serum; 1 and 3, absorbed tumour serum APF (3 mg/ml);
2, unabsorbed tumour serum APF (3 mg/ml).
as confirmed on the unabsorbed tumour
cell APF. Since the unabsorbed tumour
serum APF shared the antigenic sites
common with the unabsorbed tumour
cell APF, it was suggested that both
the unabsorbed APF may be similar or
identical in nature. On the other hand,
since the absorbed tumour serum APF
had the common antigenic property with
the absorbed normal serum APF, but
not with the unabsorbed tumour cell
APF or the unabsorbed tumour serum
APF, it was assumed that both the
absorbed APF may be similar or identical
in nature but were different from both
the unabsorbed APF. The serum of
healthy rats contained the absorbed APF
but not the unabsorbed APF. Since
both the absorbed serum APF from
healthy and tumour bearing rats were
similarly less active- for induction of
AH109A cell aggregation, and the potency
of the absorbed tumour serum APF
was independent of the duration after
i.p. inoculation of tumour cells, it was
presumed that the unabsorbed APF in
tumour bearing rat serum was released
from the tumour cell surface; the APF
potency was increased gradually accord-
ing to the duration after inoculation of
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FIG. 7. Agar immunodiffusion of tumour cell and serum APF after immunoadsoibenit chromato-
graphy. The unabsorbed tumour serum APF gave a distinct, precipitin line with antiserum
against the unabsorbed tumour cell APF, which fused one of 2 precipitin lines produce(l by the
unabsorbed tumour cell APF and the antiserum. The absorbed normal serum APF or unabsorbed
normal serum component did not give any precipitin line with the antiseruim. A, rabbit anti-
serum against, the unabsorbed tumour cell APF; 1, unabsorbed tumour serum APF (3 mg/ml);
2, unabsorbed tumour cell APF (3 mg/ml); 3, absorbed normal rat serumn APF (3 mg/ml); 4, 1un-
absorbed normal rat serum (3 mg/ml).
tumour cells.
The power to induce tumour cell
aggregation has been detected in the
serum (Tal, Dishon and Gross, 1964) and
ascitic fluid of cancer patients (Mori,
Akedo and Tanigaki, 1970) and of tumour
bearing mice (Oppenheimer and Humph-
reys, 1971). However, the problem of
whether such potency may be related to
an aggregation promoting factor of cancer
cell origin has not yet been established.
The observations reported here seemed
to give an explanation on the problem.
On the other hand, Witkowski and
Brighton (1972) have suggested a role
of serum in the attachment of human
diploid cells (MRC-5) to glass surface.
Weiss (1959a, b) also has emphasized the
role ofserum in permitting ofthe adhesion
of trypsinized culture cells ofhuman origin
to glass surface or to various gel surfaces.
However, the nature of the serum com-
ponent involved in the phenomenon has
not yet been clarified. The problem of
whether the absorbed serum APF may be
associated with the phenomenon is of
interest to investigate.
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